AllSight
Companies · OLN · Chemicals & Allied Products · Acquisition · Aug 17, 2026

Olin expands Huntsman merger disclosures as lawsuits expose valuation and synergy gaps

Merger disclosures supplementedpartly known
$6.15B 2026E Huntsman revenue vs $6.287B initially; 2027E-2030E revenue unchanged
OLIN Corp (OLN) — what happened, in plain English, and what it means versus what the market expected.

The merger itself was already known; this filing mainly addresses execution risk. Olin and Huntsman had already filed the definitive proxy materials and scheduled both shareholder votes for August 25, 2026. The new information is that two Huntsman stockholder suits, demand letters and one Olin shareholder suit allege disclosure omissions, creating a potential delay risk even though management says the claims lack merit. 〔0〕

The forecast update is largely a clarification, not a changed operating outlook. Huntsman reduced 2026E revenue from $6.287 billion to $6.150 billion, but revenue forecasts for 2027E through 2030E were unchanged; adjusted EBITDA was reduced by only $1 million in both 2029E and 2030E.

Key disclosureFiling figureComparison
Huntsman 2026E revenue$6.150B$6.287B initial projection
Huntsman 2027E revenue$6.613BLater-year forecast unchanged
Huntsman 2028E revenue$7.154BLater-year forecast unchanged
Huntsman 2029E adjusted EBITDA$914M$915M initial projection
Huntsman 2030E adjusted EBITDA$1.160B$1.161B initial projection
Huntsman 2027E unlevered free cash flow$114MRevised methodology disclosed
Huntsman 2030E unlevered free cash flow$648MRevised methodology disclosed

The buried strategic limitation is that the deal case includes no revenue synergies. The filing says management prepared no revenue-synergy estimates, leaving the combination's upside dependent on cost, integration or other operating benefits rather than top-line acceleration. 〔1〕

The added valuation detail improves disclosure but does not create a clear economic beat. The filing supplies debt, share-count, discount-rate, peer-multiple and standalone projection assumptions used by Lazard, Citi and Morgan Stanley, but it does not change the merger terms, raise expected synergies or remove the litigation overhang. Olin's board continues to recommend approval, so versus the standing deal expectation this is best read as a tactical proxy supplement: mostly in line on transaction economics, with modestly higher legal and execution friction. 〔2〕

Read the original 8-K on SEC EDGAR ↗
More from OLIN Corp (OLN)
Aug 11, 2026Quarterly dividend held at $0.20, signaling continuity rather than changeAll OLN filings, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.